Business · 23/10/20261 min read
ImmunoForge to showcase proprietary platform technologies and next-generation oncology & Phase 2 clinical pipelines at BIO-Europe 2026
Summary
Seoul, South Korea and COLOGNE, Germany, October 22, 2026 — ImmunoForge Co., Ltd. , a clinical-stage biopharmaceutical company dedicated to developing transformative therapies for rare and intractable diseases...